Thus, it is also possible that spinal TRPV1+ neuronal afferent terminals contribute to central sensitization in Ehrlich tumor pain via glutamate, although this hypothesis remains to be investigated. The gene discussed is TRPV1; the disease is Ehrlich tumor carcinoma.